Sabby Management’s Dicerna Pharmaceuticals, Inc. DRNA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2017
Q3 | – | Sell |
-190,000
| Closed | -$602K | – | 157 |
|
2017
Q2 | $602K | Sell |
190,000
-10,000
| -5% | -$31.7K | 0.04% | 53 |
|
2017
Q1 | $680K | Buy |
200,000
+100,000
| +100% | +$340K | 0.04% | 63 |
|
2016
Q4 | $288K | Buy |
100,000
+50,000
| +100% | +$144K | 0.02% | 111 |
|
2016
Q3 | $294K | Buy |
+50,000
| New | +$294K | 0.01% | 114 |
|
2015
Q1 | – | Sell |
-145,919
| Closed | -$2.4K | – | 195 |
|
2014
Q4 | $2.4K | Sell |
145,919
-114,081
| -44% | -$1.88K | 0.08% | 41 |
|
2014
Q3 | $3.31K | Buy |
260,000
+107,006
| +70% | +$1.36K | 0.13% | 22 |
|
2014
Q2 | $3.45M | Buy |
152,994
+101,484
| +197% | +$2.29M | 0.15% | 21 |
|
2014
Q1 | $1.46M | Buy |
+51,510
| New | +$1.46M | 0.08% | 43 |
|